TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Cryogenetics AS
Closing information (x1000 NOK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
40,886
|
31,177
|
28,477 |
Financial expenses |
1,074
|
940
|
751 |
Earnings before taxes |
8,580
|
3,668
|
3,688 |
Total assets |
52,192
|
44,126
|
36,715 |
Current assets |
26,268
|
23,389
|
21,256 |
Current liabilities |
8,749
|
9,636
|
7,289 |
Equity capital |
31,989
|
24,034
|
19,787 |
- share capital |
4,428
![]() |
4,428
![]() |
4,428 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
61.3%
|
54.5%
|
53.9% |
Turnover per employee | |||
Profit as a percentage of turnover |
21.0%
|
11.8%
|
13.0% |
Return on assets (ROA) |
18.5%
|
10.4%
|
12.1% |
Current ratio |
300.2%
|
242.7%
|
291.6% |
Return on equity (ROE) |
26.8%
|
15.3%
|
18.6% |
Change turnover |
9,709
|
2,700
|
5,029 |
Change turnover % |
31%
|
9%
|
21% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.